Objective. To elucidate whether there is an association between symphyseal
distention, circulating relaxin levels and pelvic pain in pregnancy.
Methods. Serum relaxin and symphyseal width were assessed in 19 consecutive
referral cases with severe pelvic pain at 35 weeks of pregnancy and in a c
ohort of 49 women at 12 and 35 weeks of pregnancy. The referral cases were
received over a period of two years and four months and the cohort was recr
uited over a period of two months. Relaxin was measured with an ELISA test
and symphyseal width assessed using ultrasonography. All women with pelvic
pain were clinically assessed. The women were divided into three groups; Gr
oup A (n=38), cohort cases with no or mild pain; Group B (n=11), cohort cas
es with disabling pain; and Group C (n=19), referral cases.
Results At 35 weeks of pregnancy mean symphyseal width was 4.5 mm (s.d. 1.0
mm) in Group A, 5.7 mm (s.d. 2.6 mm) in Group B, and 7.4 mm (s.d. 3.5 mm)
in Group C. The difference between Groups A and B is statistically signific
ant (p=0.044) as is that between Groups A and C (p<0.0001). Serum relaxin l
evels were not associated with symphyseal distention or disabling pain.
Conclusion. Severe pelvic pain during pregnancy was strongly associated wit
h an increased symphyseal distention. However, the severity of pain did not
predict the degree of symphyseal distention in the individual case, indica
ting that other mechanisms are also involved. Serum relaxin levels were not
associated with the degree of symphyseal distention or with pelvic pain in
pregnancy.